| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |